Dave Muoio
As the calendar turns to February, the beleaguered US healthcare system continues to battle an influenza season considered by Centers for Disease Control and Surveillance officials to be among the worst of this decade.
Professionals working day to day in care facilities will make an unmatched impact on their patients’ health, but much of that work is driven, for better or worse, by decisions made on Capitol Hill.
Yesterday, Dr.
San Francisco- and Zurich-based Ava, which makes a bracelet capable of tracking women’s menstrual cycles, has announced an update that will better allow their device to track when, or even if, the wearer has ovulated, according to a statement from the company.
Halo Neuroscience, a device company that develops and sells the Halo Sport neurostimulation headset, announced yesterday that it has secured $13 million in Series B funding.
A matter of national security.
In 2016, Opternative, a Chicago-based telehealth startup offering online refractive eye exams, opened a lawsuit against South Carolina’s Board of Medical Examiners and Department of Labor, Licensing, and Regulation alleging that a newly passed law restricting online eye exams was protectionist, unconstitutional legislation.
Israel-based telehealth provider and device maker Tyto Care has raised $25 million in Series C funding, the company announced today.
Omada Health has made plans with the University of Nebraska Medical Center (UNMC) and Wake Forest University to conduct the largest randomized controlled study of a digital diabetes prevention tool yet, according to the digital therapeutic company.
A team of South Korean researchers are the latest to tout a smart, glucose-sensing contact lens.